Conversely, in 61% of GC samples, the transcriptional level of VGLL4, a negative regulator of the Hippo signaling pathway, is downregulated, showing a negative correlation with GC progression, including tumor size, staging, and lymph node metastasis [135]. The gene discussed is VGLL4; the disease is gastric cancer.